arrow
H

Hennie Geldenhuys

University of Cape Town
H指数:28
被引数:3,910

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

活减毒分枝杆菌结核疫苗,MTBVAC,在有无Mycobacterium tuberculosis致敏的成人中的研究:一项单中心、1b~2a期、双盲、剂量递增、随机对照试验

2025-04-150
OAAI
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

MTBVAC在婴儿中的安全性、反应原性和免疫原性:一项在结核病流行地区进行的2a期随机、双盲、剂量定义试验

2025-04-010
PRE
Safety, reactogenicity and immunogenicity of MTBVAC in newborns in a TB endemic area: a phase 2a randomized, double-blind, dose-defining trial
2023-12-170
OA
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines
2020-10-0914
OAAI
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
2019-09-0189
OAAI
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube
2019-01-2112
OAAI
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations A Double-Blind, Placebo-controlled, Dose-Selection Trial

H56的剂量优化: 结核病流行人群的IC31疫苗双盲,安慰剂对照,剂量选择试验

2019-01-1583
PREAI
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
2018-07-12494
OAAI
Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection
2017-09-01118
OAAI
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
2014-10-23346
OAAI
Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

新型结核病疫苗M72/AS01在南非成年人中诱导和调节T细胞免疫

2013-08-15106
OA